4//SEC Filing
Catinazzo Thomas 4
Accession 0000950170-25-047725
CIK 0001812364other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 4:13 PM ET
Size
6.6 KB
Accession
0000950170-25-047725
Insider Transaction Report
Form 4
Catinazzo Thomas
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-03-27$2.84/sh−298$846→ 379,133 total - Sale
Common Stock
2025-03-27$2.84/sh−4,566$12,967→ 374,567 total
Footnotes (3)
- [F1]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on March 26, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- [F2]Includes 254,354 shares underlying RSUs.
- [F3]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024.
Documents
Issuer
Relay Therapeutics, Inc.
CIK 0001812364
Entity typeother
Related Parties
1- filerCIK 0001818261
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 4:13 PM ET
- Size
- 6.6 KB